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ABSTRACT 
Objective: To examine the role of the IRF6 mutations in Polish families with Van der Woude 
syndrome (VWS) and popliteal pterygium syndrome (PPS) and to determine the effect of 
IRF6 single nucleotide polymorphisms (rs7552506, rs2013162, and rs2235375) in CL/P 
susceptibility. 
Design: IRF6 mutation screening was performed by direct sequencing of all coding exons of 
the gene and their flanking intronic regions. Cosegregation analysis was performed to 
establish the relation of SNPs and CL/P phenotypes. 
Patients: We screened the IRF6 gene in 8 families with clinical recognition of VWS and PPS. 
Results: In 5 families we identified pathogenic mutations, all affecting the DNA-binding or 
the protein-binding domain of IRF6. Two of the mutations were novel – a missense mutation 
Arg31Thr and a small deletion Trp40Glyfs*23. In most cases we found also a haplotype of 
three SNPs - rs7552506, rs2013162, and rs2235375. The association of the SNPs and CL/P 
susceptibility had been previously published. The variants did not cosegregate with phenotype 
in examined families nor did they cosegregate with pathogenic mutations. The SNPs were not 
causative, due to their presence in unaffected family members.  
Conclusions: Two novel mutations (Arg31Thr and Trp40Glyfs*23) in the IRF6 gene were 
identified to be causative for VWS and PPS syndromes. In the present study no association 
between the SNPs - rs7552506, rs2013162, and rs2235375 and the CL/P phenotype was 
found. The hypothesis, whether the haplotype of the three SNPs was correlated with IRF6 
expression level, demands further investigation. 
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INTRODUCTION 
Clefts of the lip and/or palate (CLP) are common birth defects of complex genetic/ 
environmental etiology affecting ~1 in 700 individuals worldwide. It is estimated that 70% 
cases of CLP occur as isolated entities, commonly termed non-syndromic CLP (NSCLP), 
with no other apparent cognitive or craniofacial structural abnormalities (Dixon et al., 2011). 
The remaining 30% cases of orofacial clefts are composed of a wide range of malformation 
syndromes, including over 500 Mendelian syndromes (www.omim.org). Such CLP cases are 
designated as syndromic, and Van der Woude syndrome (VWS, MIM# 119300) is among the 
most common, accounting for ~2% of all clefts (Kondo et al, 2002). VWS is characterized by 
clefts of the lip and/or palate (CL/P) and congenital lower lip pits (LP). It is one of two allelic 
autosomal dominant disorders caused by mutations in the IRF6 gene. The second one, 
popliteal pterygium syndrome (PPS, MIM# 119500) is characterized by the clinical features 
of VWS (CL/P and LP), with additional symptoms that include webbing of skin behind the 
knees (pterygia), genital anomalies, syndactyly, and other anomalies (Leslie et al., 2013). 
However, mutations in IRF6 have been also shown to cause a nonsyndromic, isolated form of 
clefting (Rutledge et al., 2010).  
The interferon regulatory factor-6 gene (IRF6, OMIM# 607199), located in 
chromosome 1q32.2, belongs to a family of nine transcription factors that share a highly-
conserved helix-turn-helix (HTH) DNA-binding domain and a less conserved protein-binding 
domain. Most IRFs regulate the expression of interferon - alpha and - beta after viral 
infection. Unlike the other IRFs, the IRF6 gene is involved in orofacial development, 
especially in cell adhesion and fusion during lip and palate formation. More precisely, the 
gene is a key determinant of the keratinocyte proliferation–differentiation switch, and has a 
crucial role in the formation of oral periderm, spatiotemporal regulation of which is essential 
for ensuring appropriate palatal adhesion (Dixon et al., 2011). Mutations in IRF6 causing 
  
haploinsufficiency of the gene have been shown to disrupt orofacial development leading to 
lip and/or palate clefting (Kondo et al., 2002). Common alleles of IRF6  (Wu-Chou et al., 
2013), as well as variants located within the IRF6 enhancer (Rahimov et al., 2008), were also 
associated with CLP. The aim of this study was to examine the role of the IRF6 mutations in 
Polish patients with CLP and to determine the effect of IRF6 common variants in CLP 
susceptibility. 
MATERIALS AND METHODS 
We screened the IRF6 gene in 8 families with clinical recognition of VWS and PPS. 
Genomic DNA was extracted from blood leukocytes using standard techniques. All DNA 
samples were obtained with participants’ written informed consent. All coding exons of IRF6 
(exons 3-9) and their flanking intronic regions were amplified with primers (Table 1) 
designed using the Primer 3 software (http://frodo.wi.mit.edu). PCR amplifications were 
performed with 100 ng of genomic DNA template using Taq DNA Polymerase (Thermo 
Fisher Scientific). The PCR products were purified using ExoSAP-IT (Affymetrix) and then 
directly sequenced on both strands. The sequences were analyzed using the Mutation 
Surveyor software (Softgenetics, LLC) in comparison to the reference sequence 
NM_006147.2 (NCBI RefSeq; http://www.ncbi.nlm.nih.gov/nuccore). In silico analysis was 
performed using the PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2), MutPred 
(http://mutpred.mutdb.org) and Mutation Taster (http://www.mutationtaster.org) methods. 
The SNP frequencies were determined using the HapMap Project web site 
(http://hapmap.ncbi.nlm.nih.gov). To exclude the possibility of the newly identified mutations 
being common variants, their existence in public databases was checked using dbSNP – Short 
Genetic Variation (http://www.ncbi.nlm.nih.gov/SNP/), 1000 genomes - A Deep Catalog of 
Human Genetic Variation (http://browser.1000genomes.org/index.html), and EVS - Exome 
Variant Server (http://evs.gs.washington.edu/EVS/).  The structural effect of the Arg31Thr 
  
substitution was analyzed with the homology modeling of N-terminal 120 residue fragment of 
IRF6 using Yasara Structure software. Eight structures from Protein Data Bank (PDB) - 1IRF, 
2IRF (Irf-2); 2PI0, 2O61, 2O6G, 3QU6, 1T2K (Irf-3); 2DLL (Irf- 4) and 3QU3 (Irf-7) were 
selected as the best templates for homology modeling, each of them covering over 90% of Irf-
6 DNA binding domain (DBD). In order to assess possible modulation of protein-DNA 
interactions the modeled structure of Irf-6 was aligned with the known structure of the 
complex of Irf-3 with DNA (PDB record 2O6G) using Mustang algorithm implemented in 
Yasara Structure. The high homology between the template and target proteins (51 identical 
and 37 similar among 120 residues) resulted in the reasonable quality model of Irf-6 in 
complex with DNA duplex.  
RESULTS 
In 5 families from those referred to our laboratory we identified two heterozygous 
missense mutations and two small deletions, all affecting the DNA-binding or the protein-
binding domain. The mutations we found were either known (Arg84Cys, Pro246Leufs*57) or 
novel (Arg31Thr, Trp40Glyfs*23). 
In two families with PPS we found known mutation c. 250C>T, p. Arg84Cys affecting 
the DNA binding domain (DBD). In family 1 (Fig. 1) the mutation arose de novo. The 
proband was the only affected member of the family and the only one in whom the mutation 
was identified. He demonstrated unilateral cleft lip and palate, lip pits, cleft scrotum, partial 
lid synechiae, syndactyly, and popliteal pterygia. The second family with PPS (family 2, Fig. 
1) exhibited the same Arg84Cys mutation. There were four affected members over three 
generations in this family. The mutation expression was variable – all of the patients 
demonstrated pterygia and syndactyly characteristic for PPS, while orofacial abnormalities 
ranged from none, through lip pits only, to unilateral cleft lip and palate - suggesting 
existence of other genetic modifiers in this family.  
  
The other mutation we found (c. 737delC, p. Pro246Leufs*57) was located in the 
second functional domain of IRF6, which is engaged in protein binding. It is a known 
mutation that causes a frameshift and thus protein truncation. The mutation was found in a 
family with VWS (family 3) and there were four affected members over three generations 
(Fig. 1). The expression of the mutation was also variable, ranging from lip pits alone (father) 
to lip pits and unilateral cleft lip and palate (proband).  
In the region coding DBD, in two families with VWS, we identified two novel 
mutations (p. Arg31Thr and p. Trp40Glyfs*23) that have not been reported in the literature so 
far. In family 4 (Fig. 1) we identified a mutation (c. 92G>C, p. Arg31Thr) located in exon 3 
of the IRF6 gene. There were two affected persons in this family – the mother, who 
demonstrated only lip pits, and her daughter, who had cleft palate. We identified the 
Arg31Thr mutation only in mother, because she hasn’t given consent for molecular analysis 
in her underage child. However, in silico analysis (Mutation Taster, MutPred, PolyPhen-2) 
predicted the character of the mutation as disease causing. Additionally, the variant was 
absent in dbSNP, 1000 genomes and EVS databases, which excludes the possibility of it 
being a common one. To prove the variant as a pathogenic mutation we performed structural 
modeling of the N-terminal fragment of Irf-6 bound to DNA. The analysis demonstrates that 
Arg31 (Lys29 in Irf-3) is involved in salt bridging/hydrogen bonding with the Asp19 side 
chain (Asp17 in Irf-3). This interaction fixes the orientation of N-terminal helix1 Arg9-Gly21 
(Arg7-Gly19 in irf-3) against the three-strand beta-sheet, and consequently fastens helix-turn-
helix (HTH) DNA-binding motif (Fig. 2). It could be thus expected that substitution 
Arg31Thr will interfere with DNA binding.  
The second novel mutation we found was also located in the region encoding DBD 
(exon 3). It was a small deletion (c. 117delC), which resulted in a frameshift (p. 
Trp40Glyfs*23) and thus protein truncation. The deletion was predicted as disease causing 
  
(Mutation Taster) and it was absent in dbSNP, 1000 genomes and EVS databases, excluding 
the possibility of being a common variant. The mutation was found in family 5 (Fig. 1) and 
there were three affected persons over three generations. The expression of mutation was 
variable, ranging from lip pits in the mother (Fig. 3B), through lip pits and cleft palate in the 
grandfather, to the most severe phenotype in our cohort, in the proband, characterized by 
bilateral cleft of the lip and palate and lid synechiae (Fig. 3A).  
In three patients (probands 6, 7, and 8) with recognition of VWS (CLP and lid 
synechiae), PPS (CL and popliteal pterygium of the left limb), and VWS (buccal synechiae 
and cleft of the secondary palate), respectively, we did not find any pathogenic mutations in 
the IRF6 coding region. The patients had no familial history of oral clefts (sporadic cases).  
Excepting for IRF6 mutations, in most cases we found also three IRF6 single 
nucleotide polymorphisms:  SNP1 - c.175-5C>G (rs7552506), SNP2 - c.459G>T 
(rs2013162), and SNP3 - c. 667+27C>G (rs2235375). SNP 1 and 3 are intronic variants 
(intron 3-4 and intron 6-7, respectively), while SNP2 results in a silent polymorphism in exon 
5, which does not change the protein product (Ser153Ser). We identified the SNPs in 
probands 6, 7, and 8, who did not demonstrate any IRF6 mutations. The SNPs were also 
present in all the families with IRF6 pathogenic mutations, but they located on a different 
allele than the mutation was. Inheritance and segregation of the SNPs in the examined 
families (Fig. 1) show that all the minor alleles have been inherited from the same parent. 
This allows us to assume the three SNPs as a haplotype. 
The patient in family 1 with a de novo mutation was the only proband in whom the 
SNPs were not found. However, the SNPs were present in both his parents. We also identified 
the existence of the haplotype in family 2. The SNPs did not segregate with the disease 
phenotype, nor did they segregate with the Arg84Cys mutation - there was an affected person 
with mutation and without SNPs and there was an unaffected one with SNPs but without the 
  
mutation. In this family it appears that the SNPs were insufficient to evoke the syndrome 
alone, but magnified the symptoms caused by the pathogenic Arg84Cys mutation. The 
patients with the mutation and SNPs demonstrated more severe symptoms than the patients 
with the mutation alone. It could have been speculated that the SNPs were genetic modifiers 
that can influence expression of IRF6, but this hypothesis requires further investigation. In 
family 3 in the proband and his healthy mother we identified the SNP haplotype as well. Like 
in the other families, the SNPs were not associated with the mutation. On the basis of existing 
data, it is impossible to exclude the hypothesis of magnification of the symptoms by the 
haplotype. Also in family 4, in the mother, we identified the haplotype, but because of the 
lack of molecular examination of her daughter, the hypothesis of SNP magnification can not 
be excluded. Finally, in family 5 we identified the same SNP haplotype. It was found in the 
proband and in both parents, but not in the affected grandfather. The SNP haplotype was not 
associated with the mutation and it did not segregate with the disease phenotype. The mother 
who had only the lip pits, as well as the daughter who had bilateral cleft lip and palate, 
demonstrated the same SNP haplotype. Thus, the SNPs cannot be assumed as genetic 
modifiers that differentiate disease symptoms. Moreover, the grandfather who had the 
mutation and no SNPs, demonstrated a more severe phenotype than the mother with both the 
mutation and the SNPs. On the basis of this family data, the hypothesis of SNP magnification 
must be excluded.  
DISCUSSION 
We found the IRF6 gene as frequently mutated in the cohort of our families with CLP 
(0.63). In two families we found the Arg84Cys mutation, the most frequent substitution 
among the IRF6 mutations. It localizes in a mutational hotspot attributed to a CpG 
dinucleotide in this codon, which undergoes methylation and spontaneous deamination of 
cytosine to thymine. Missense mutations at CpG are responsible for a half of PPS families and 
  
the majority of these are Arg84Cys substitutions (Leslie et al., 2013). The mutation affects 
DBD, which is crucial in functioning of IRF6 as a transcription factor. The substitution results 
in a complete loss of contact with DNA, and thus makes DNA binding impossible (Kondo et 
al., 2002, Little et al., 2009). 
We found also two novel IRF6 mutations: Arg31Thr and Trp40Glyfs*23. The 
Arg31Thr substitution is located in the region encoding the DNA binding domain (amino 
acids 13-113) and it affects an amino acid that is highly conserved. According to structural 
modeling, which we performed, the mutation interferes with DNA binding. Thus, it disturbs 
the functioning of IRF6 as a transcription factor. This result, together with the absence of the 
variant in SNP databases, let us assume the Arg31Thr substitution as a pathogenic mutation 
leading to VWS phenotype. 
The second novel mutation we found was a small deletion (c. 117delC), which 
resulted in a frameshift (p. Trp40Glyfs*23) and protein truncation as a consequence. 
According to the HGMD database (http://www.hgmd.org/), the majority of IRF6 mutations 
(about 70%) are of missense type, whereas rearrangements are almost absent (2%). Small 
deletions, such as the one we identified, are relatively rare mutations among those found in 
IRF6. They account for about 14% of all IRF6 mutations.  
So far, about 300 different mutations in the IRF6 gene have been described. 
Nonpathogenic, polymorphic variants in the IRF6 gene have also been found to be 
significantly associated with oral clefting in many different populations and ethnic groups 
(Wu-Chou et al., 2013). Zucchero et al. (2004) found a higher risk of recurrence of NSCL/P 
for carriers of the C base (Val274) of rs2235371 polymorphism. They demonstrated that 
individuals heterozygous for this specific polymorphism (CT genotype) have a lower 
recurrence risk of CL/P than individuals homozygous for the C allele (CC genotype). In all 
the presented families, rs2235371 was seen as a monomorphic risk allele (CC genotype) and 
  
can therefore contribute to the CLP phenotype, especially in patients, in whom no pathogenic 
IRF6 variants have been found (probands 6, 7, and 8).  
In the affected individuals we also found a haplotype of additional IRF6 single 
nucleotide polymorphisms: SNP1 (rs7552506), SNP2 (rs2013162), and SNP3 (rs2235375). It 
was shown that the SNPs 1, 2, and 3 were associated with CLP. Scapoli et al. (2005) 
demonstrated the linkage disequilibrium between SNP2 and SNP3 and, in addition, an 
association with the NSCL/P phenotype in an Italian population. Pegelow et al. (2008) found 
an association between SNP1 and the CLP phenotype in a Swedish population. The extent of 
the contribution of the IRF6 SNPs for oral clefting susceptibility in Polish patients is still 
unknown. The SNPs we found have never been tested for association in Polish patients. The 
SNPs are of high frequency, according to the HapMap Project 
(http://hapmap.ncbi.nlm.nih.gov/) each of the three SNPs accounts for equally 32% in the 
Italian population (which, among all the HapMap populations, is the closest to the Polish one) 
suggesting the existence of linkage disequilibrium between the variants. According to 1000 
Genomes project, the minor allele frequencies of the three SNPs were also at the level of 
about 30% in five European subpopulations (Finnish, British, Iberian, Toscanini, and in Utah 
European ancestors). We identified the SNP haplotype in all the families that carried 
heterozygous IRF6 mutations, but on a different allele. We also found the haplotype in three 
patients with CLP, who did not demonstrate any pathogenic IRF6 mutations. The variants did 
not cosegregate with pathogenic mutations, nor with the phenotype in examined families. The 
SNPs were not causative, because they were present in unaffected family members. It was 
hypothesized that different IRF6 polymorphic variants interfere in the proper expression of 
the gene in critical moments of embryonic craniofacial development and thus contribute to the 
occurrence of CLP (Brito et al., 2012). The expression of IRF6 mutations found in the 
examined families was variable, suggesting the existence of other genetic determinants 
  
modifying the phenotypic outcome. However, in the present study no association between the 
three SNPs and the CLP phenotype was found. The hypothesis, whether the haplotype of the 
three SNPs was correlated with IRF6 transcriptional expression level, demands further 
investigation, especially functional analysis and association studies on a large cohort in the 
Polish population. The chance of incomplete penetrance should be also taken into account. 
 Recently, a new gene causing VWS, grainy-head-like 3 (GRHL3), has been 
discovered. This second gene causing VWS was found in a Finnish VWS sample, where 
pathogenic variants of IRF6 have been excluded (Peyrard-Janvid et al., 2014). This finding 
will, in the future, contribute to the need of further investigation of the probands in our study 
excluded for IRF6. 
CONCLUSIONS 
The segregation of alleles found in the families with CLP does not confirm the 
hypothesis of symptom magnification by the haplotype of three IRF6 SNPs (rs7552506, 
rs2013162, and 2235375). On the other hand, identifying of two novel mutations (p. 
Arg31Thr and p. Trp40Glyfs*23) will be important for proper genetic counseling, because 
CLP, due to an IRF6 mutation, is not expected to be associated with serious medical 
complications, such as intellectual disability or developmental delay. 
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FIGURE LEGENDS 
Fig.1  
Pedigrees of examined families with orofacial clefting. uCLP, unilateral cleft lip and palate; 
bCLP, bilateral cleft lip and palate; LP, lip pits; LS, lid synechiae; GA, genital anomalies. The 
genotypes of all the patients available for molecular analyses are indicated in the pedigrees. 
Mutations of the IRF6 gene are annotated at the protein level. Sequence chromatograms 
derived from the affected probands are shown below the pedigrees. SNPs placed in the box 
denote a haplotype of three single nucleotide polymorphisms in the IRF6 gene: SNP1 - 
rs7552506, SNP2 - rs2013162, and SNP3 – 2235375.  
Fig. 2 
Structural modeling of the N-terminal fragment of Irf-6 (bottom) bound to DNA (top). 
Arg31 (right bottom corner) is involved in salt bridging/hydrogen bonding with the 
Asp19 side chain. This interaction fixes the orientation of N-terminal helix against the 
three-strand beta-sheet, and consequently fastens DNA-binding motif.  
Fig. 3  
Clinical variability in the two affected individuals in family 5. The proband (3A) presenting 
bilateral cleft of the lip and palate and lid synechiae, and the mother (3B) presenting lip pits 
only. The phenotype was evoked by a small deletion  c. 117delC, p. Trp40Glyfs*23 in the 
IRF6 gene. 
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